Login Register Cart 0
Generic placeholder image

Mini-Reviews in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1389-5575
ISSN (Online): 1875-5607

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Synthesis of Azoloquinazolines and Substituted Benzothiazepine as Antimicrobial Agents

Author(s): Asmaa F. Kassem, Fatimah Alshehrei, Eman M.H. Abbas and Thoraya A. Farghaly*

Volume 20, Issue 5, 2020

Page: [418 - 429] Pages: 12

DOI: 10.2174/1389557519666190603091101

Price: $65

Abstract

Background & Objective: Quinazolines and their fused systems are noteworthy in pharmaceutical chemistry due to their wide range of biological activities.

Methods: A direct and efficient approach for the synthesis of new series of fused quinazolines with triazole, thiazole, benzimidazole and tetrazole has been preceded via the reaction of quinazoline thione derivative with halogenated compounds or cyclocondensation of arylidene of quinazoline derivative with heterocyclic amines. Also, dibenzo[b,e][1,4]thiazepine derivatives was synthesized through the reaction of 2,6-bis-(2-chloro-benzylidene)-cyclohexanone with o-aminothiophenol.

Results: The structures of all new synthesized heterocyclic compounds were confirmed and discussed on the bases of spectral data. The utility of the preparation and design of the above mentioned compounds has been shown to be clear in the results of their antimicrobial activity which revealed that some derivatives have potent activity exceeding or similar to the activity of the reference drugs.

Conclusion: The insertion of triazole or thiazole moieties to be fused with quinazoline ring helps to enhance its antimicrobial activity.

Keywords: Azoloquinazolines, hydrazonoyl chlorides, benzothiazepine, thiazoles, triazoles, antimicrobial agents.

« Previous
Graphical Abstract

[1]
Samira, I.; Patel, S.; Hasmin, M.; Patel, S. Biological profile of quinazoline. Int. J. Pharm. Chem. Sci., 2012, 1, 1863-1872.
[2]
Singh, V.K.; Singh, S.K.; Gangwar, L. Synthesis and antimicrobial activity of novel fused 4-(3H) quinazolinone derivatives. Int. J. Sci. Res. (Ahmedabad), 2013, 2, 425-428.
[3]
Ghorab, M.M.; Ismail, Z.H.; Radwan, A.A.; Abdalla, M. Synthesis and pharmacophore modeling of novel quinazolines bearing a biologically active sulfonamide moiety. Acta Pharm., 2013, 63(1), 1-18.
[http://dx.doi.org/10.2478/acph-2013-0006] [PMID: 23482309]
[4]
Vijayakumar, K.; Ahamed, A.J.; Thiruneelakandan, G. Synthesis, antimicrobial, and anti-HIV1 activity of quinazoline-4(3H)-one derivatives. J. Appl. Chem., 2013, 2013ID387191
[5]
Deep, A.; Narasimhan, B.; Ramasamy, K.; Mani, V.; Mishra, R.K.; Majeed, A.B. Synthesis, antimicrobial, anticancer evaluation and QSAR studies of thiazolidin-4-ones clubbed with quinazolinone. Curr. Top. Med. Chem., 2013, 13(16), 2034-2046.
[http://dx.doi.org/10.2174/15680266113139990130] [PMID: 23895092]
[6]
Al-Amiery, A.A.; Kadhum, A.A.H.; Shamel, M.; Satar, M.; Khalid, Y.; Mohamad, A.B. Antioxidant and antimicrobial activities of novel quinazolinones. Med. Chem. Res., 2014, 23, 236-242.
[http://dx.doi.org/10.1007/s00044-013-0625-1]
[7]
De Clercq, E. New developments in anti-HIV chemotherapy. Curr. Med. Chem., 2001, 8(13), 1543-1572.
[http://dx.doi.org/10.2174/0929867013371842] [PMID: 11562282]
[8]
Laddha, S.S.; Wadod Kar, S.G.; Meghal, S.K. Studies on some biologically active substituted 4(3H)-quinazolinones. Part 1. Synthesis, characterization and anti-inflammatory, antimicrobial activity of 6,8-disubstituted 2-phenyl-3-[substituted- benzothiazol-2-yl]-4(3H)-quinazolinone. ARKIVOC, 2006, 11, 1-20.
[9]
Giri, R.S.; Thaker, H.M.; Giordano, T.; Williams, J.; Rogers, D.; Sudersanam, V.; Vasu, K.K. Design, synthesis and characterization of novel 2-(2,4-disubstituted-thiazole-5-yl)-3-aryl-3H-quinazoline-4-one derivatives as inhibitors of NF-kappaB and AP-1 mediated transcription activation and as potential anti-inflammatory agents. Eur. J. Med. Chem., 2009, 44(5), 2184-2189.
[http://dx.doi.org/10.1016/j.ejmech.2008.10.031] [PMID: 19064304]
[10]
LeMahieu, R.A.; Carson, M.; Welton, A.F.; Baruth, H.W.; Yaremko, B. Synthesis and antiallergy activity of 5-oxo-5H-thiazolo[2,3-b]quinazolinecarboxylic acids. J. Med. Chem., 1983, 26(1), 107-110.
[http://dx.doi.org/10.1021/jm00355a022] [PMID: 6827522]
[11]
Jiang, S.; Zeng, Q.; Gettayacamin, M.; Tungtaeng, A.; Wannaying, S.; Lim, A.; Hansukjariya, P.; Okunji, C.O.; Zhu, S.; Fang, D. Antimalarial activities and therapeutic properties of febrifugine analogs. Antimicrob. Agents Chemother., 2005, 49(3), 1169-1176.
[http://dx.doi.org/10.1128/AAC.49.3.1169-1176.2005] [PMID: 15728920]
[12]
Khosropour, A.R.; Mohammadpoor-Baltork, I.; Ghorbankhani, H. Bi (TFA) 3-[nbp] Fecl4: A new, efficient and reusable promoter system for the synthesis of 4(3H)-quinazolinone derivatives. Tetrahedron Lett., 2006, 47, 3561-3564.
[http://dx.doi.org/10.1016/j.tetlet.2006.03.079]
[13]
Khalil, A.A. Abdel hamide S. G., Al-Obaid A. M., El-subbagh H. Substituted quinazolinones, Part2. Synthesis and in vitro anticancer evaluation of new 2-substituted mercapto-3H-quinazolin analogs. Arch. Pharm. Pharm. Med. Chem., 2003, 336, 95-103.
[http://dx.doi.org/10.1002/ardp.200390011] [PMID: 12761762]
[14]
Nagar, A.A.; Rathi, L.G.; Chugh, N.; Pise, V.J.; Bendale, A. Microwave assisted one pot synthesis of 2, 3-di-substituted quinazolin-4- (3H)-ones and their potential biological activity. Pharma Chem., 2010, 2, 37-43.
[15]
Hattori, K.; Kido, Y.; Yamamoto, H.; Ishida, J.; Iwashita, A.; Mihara, K. Rational design of conformationally restricted quinazolinone inhibitors of poly(ADP-ribose)polymerase. Bioorg. Med. Chem. Lett., 2007, 17(20), 5577-5581.
[http://dx.doi.org/10.1016/j.bmcl.2007.07.091] [PMID: 17804225]
[16]
Guiles, J.; Sun, X.; Critchley, I.A.; Ochsner, U.; Tregay, M.; Stone, K.; Bertino, J.; Green, L.; Sabin, R.; Dean, F.; Dallmann, H.G.; McHenry, C.S.; Janjic, N. Quinazolin-2-ylamino-quinazolin-4-ols as novel non-nucleoside inhibitors of bacterial DNA polymerase III. Bioorg. Med. Chem. Lett., 2009, 19(3), 800-802.
[http://dx.doi.org/10.1016/j.bmcl.2008.12.038] [PMID: 19109016]
[17]
Orvieto, F.; Branca, D.; Giomini, C.; Jones, P.; Koch, U.; Ontoria, J.M.; Palumbi, M.C.; Rowley, M.; Toniatti, C.; Muraglia, E. Identification of substituted pyrazolo[1,5-a]quinazolin-5(4H)-one as potent poly(ADP-ribose)polymerase-1 (PARP-1) inhibitors. Bioorg. Med. Chem. Lett., 2009, 19(15), 4196-4200.
[http://dx.doi.org/10.1016/j.bmcl.2009.05.113] [PMID: 19541484]
[18]
Al-Rashood, S.T.; Aboldahab, I.A.; Nagi, M.N.; Abouzeid, L.A.; Abdel-Aziz, A.A.M.; Abdel-Hamide, S.G.; Youssef, K.M.; Al-Obaid, A.M.; El-Subbagh, H.I. Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4(3H)-quinazolinone analogs. Bioorg. Med. Chem., 2006, 14(24), 8608-8621.
[http://dx.doi.org/10.1016/j.bmc.2006.08.030] [PMID: 16971132]
[19]
Liu, S.; Liu, F.; Yu, X.; Ding, G.; Xu, P.; Cao, J.; Jiang, Y. The 3D-QSAR analysis of 4(3H)-quinazolinone derivatives with dithiocarbamate side chains on thymidylate synthase. Bioorg. Med. Chem., 2006, 14(5), 1425-1430.
[http://dx.doi.org/10.1016/j.bmc.2005.09.064] [PMID: 16263296]
[20]
Selvam, T.P.; Kumar, P.V. Quinazoline Marketed drugs - A Review. Res Pharm., 2011, 1, 1-21.
[21]
Abida, P.N.; Rana, A.; Imran, M. An updated review: newer quinazoline derivatives under clinical trial. Int. J. Pharm. Biol. Arch., 2011, 2, 1651-1657.
[22]
Mohamed, M.A.; Ghanem, H.M.; Abd El-Ghaffar, N.F.; Mohamed, S.S. Biological evaluation and molecular docking of substituted quinazolinones as antimicrobial agents. Aust. J. Basic Appl. Sci., 2013, 7, 263-274.
[23]
F. Zayed, M.; H Hassan, M. Synthesis and biological evaluation studies of novel quinazolinone derivatives as antibacterial and anti-inflammatory agents. Saudi Pharm. J., 2014, 22(2), 157-162.
[http://dx.doi.org/10.1016/j.jsps.2013.03.004] [PMID: 24648828]
[24]
El-Badry, Y.A.; Anter, N.A.; El-Sheshtawy, H.S. Synthesis and evaluation of new polysubstituted quinazoline derivatives as potential antimicrobial agents. Pharma Chem., 2012, 4, 1361-1370.
[25]
Dave, R.S.; Odedara, R.R.J.; Kalaria, R.I.; Upadhyay, J.J. Synthesis, characterization and antimicrobial activity of new quinazolin- 4(3H)-one Schiff base derivatives. J. Chem. Pharm. Res., 2012, 4, 4864-4869.
[26]
Desai, N.C.; Dodiya, A.; Shihory, N. Synthesis and antimicrobial activity of novel quinazolinone-thiazolidine–quinoline compounds. J. Saudi Chem. Soc., 2013, 17, 259-267.
[http://dx.doi.org/10.1016/j.jscs.2011.04.001]
[27]
Jantová, S.; Stankovský, Š.; Špirková, K. In vitro antibacterial activity of ten series of substituted quinazolines. Biologia (Bratisl.), 2004, 59(6), 741-752.
[28]
Ayati, A.; Emami, S.; Asadipour, A.; Shafiee, A.; Foroumadi, A. Recent applications of 1,3-thiazole core structure in the identification of new lead compounds and drug discovery. Eur. J. Med. Chem., 2015, 97, 699-718.
[http://dx.doi.org/10.1016/j.ejmech.2015.04.015] [PMID: 25934508]
[29]
Chhabria, M.T.; Patel, S.; Modi, P.; Brahmkshatriya, P.S. Thiazole: A review on chemistry, synthesis and therapeutic importance of its derivatives. Curr. Top. Med. Chem., 2016, 16(26), 2841-2862.
[http://dx.doi.org/10.2174/1568026616666160506130731] [PMID: 27150376]
[30]
Maienfisch, P.; Edmunda, A.J.F. Chapter three - thiazole and isothiazole ring-containing compounds in crop protection. Adv. Heterocycl. Chem., 2017, 121, 35-88.
[http://dx.doi.org/10.1016/bs.aihch.2016.04.010]
[31]
Kumar, S.S.; Kavitha, H.P. Synthesis and biological applications of triazole derivatives – A Review. Mini Rev. Org. Chem., 2013, 10, 40-65.
[32]
Farghaly, T.A.; Abdallah, M.A.; Mahmoud, H.K. Synthesis of novel 1,2,4-Triazoles and triazolo-thiadiazines as anticancer agents. Turk. J. Chem., 2015, 39, 955-969.
[http://dx.doi.org/10.3906/kim-1504-13]
[33]
Singhal, N.; Sharma, P.K.; Dudhe, R.; Kumar, N. Recent advancement of triazole derivatives and their biological significance. J. Chem. Pharm. Res., 2011, 2, 126-133.
[34]
Jasass, R.S.; Alshehrei, F.; Farghaly, T.A. Microwave‐Assisted synthesis of antimicrobial agents containing carbazole and thiazole moieties. J. Heterocycl. Chem., 2018, 2099-2106.
[http://dx.doi.org/10.1002/jhet.3253]
[35]
Masaret, G.S.; Farghaly, T.A. Synthesis of 8,10-disubstituted-triazoloperimidines from (E)-3-(dimethylamino)-1-(8-phenyl-8H-[1,2,4]triazolo[4,3-a]perimidin-10-yl)prop-2-en-1-one and their antimicrobial activity. Curr. Org. Synth., 2018, 15(1), 126-136.
[http://dx.doi.org/10.2174/1570179414666170601121137]
[36]
Mabkhot, Y.N.; Kaal, N.A.; Alterary, S.; Al-Showiman, S.S.; Farghaly, T.A.; Mubarak, M.S. Antimicrobial activity of thiophene derivatives derived from ethyl (E)-5-(3-(dimethylamino)acryloyl)-4-methyl-2-(phenylamino)thiophene-3-carboxylate. Chem. Cent. J., 2017, 11(1), 75.
[http://dx.doi.org/10.1186/s13065-017-0307-z] [PMID: 29086901]
[37]
Farghaly, T.A.; Abdallah, M.A.; Masaret, G.S.; Muhammad, Z.A. New and efficient approach for synthesis of novel bioactive [1,3,4]thiadiazoles incorporated with 1,3-thiazole moiety. Eur. J. Med. Chem., 2015, 97, 320-333.
[http://dx.doi.org/10.1016/j.ejmech.2015.05.009] [PMID: 26055810]
[38]
El-Gamel, N.E.A.; Farghaly, T.A. Design and synthesis of novel complexes containing N-phenyl-1H-pyrazole moiety: Ni complex as potential antifungal and antiproliferative compound. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2013, 115, 469-475.
[http://dx.doi.org/10.1016/j.saa.2013.06.067] [PMID: 23871973]
[39]
El-Sayed, R.; Wasfy, A.A.F.; Aly, A.A. Synthesis of novel heterocycles with antimicrobial and surface activity. J. Heterocycl. Chem., 2005, 42, 125-130.
[http://dx.doi.org/10.1002/jhet.5570420119]
[40]
Al-Omary, F.A.M.; Hassan, G.S.; El-Messery, S.M.; El-Subbagh, H.I. Substituted thiazoles V. synthesis and antitumor activity of novel thiazolo[2,3-b]quinazoline and pyrido[4,3-d]thiazolo[3,2-a]pyrimidine analogues. Eur. J. Med. Chem., 2012, 47(1), 65-72.
[http://dx.doi.org/10.1016/j.ejmech.2011.10.023] [PMID: 22056277]
[41]
Selvam, T.P.; Kumar, P.V. Synthesis of Novel 6,7,8,9-Tetrahydro-5H-5-hydroxyphenyl-2-benzylidine-3-substituted Hydrazino Thiazolo (2,3-b) Quinazoline as potent antinociceptive and anti-inflammatory agents. Bull. Korean Chem. Soc., 2010, 31, 3265-3271.
[http://dx.doi.org/10.5012/bkcs.2010.31.11.3265]
[42]
Pfaller, M.A.; Burmeister, L.; Bartlett, M.S.; Rinaldi, M.G. Multicenter evaluation of four methods of yeast inoculum preparation. J. Clin. Microbiol., 1988, 26(8), 1437-1441.
[PMID: 3049651]

Rights & Permissions Print Cite
Article Metrics
26
1
World Chagas Disease
© 2024 Bentham Science Publishers | Privacy Policy